Eisai Co., Ltd.

Eisai is a global, research-based pharmaceutical company headquartered in Tokyo, Japan, with a strong focus on prescription medicines. Guided by its 'human health care' (hhc) philosophy, the company prioritizes the needs of patients and their families in its drug discovery, development, and marketing efforts. Eisai has established itself as a leader in neurology and oncology, two areas with significant unmet medical needs. The company leverages advanced technologies, including Deep Human Biology Learning (DHBL), to drive innovation and develop targeted therapies for challenging conditions such as Alzheimer's disease and various cancers.